Clinical trial
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
NCT05026749 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- February 27, 2022
- Completion date
- July 31, 2028
- Enrollment
- 370 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.